Sydney M Crago

5 days ago | modernretina.com | Sydney M Crago

May 11, 2025Katherine Talcott, a retina specialist at Cole Eye Institute at the Cleveland Clinic, presented at the Retinal World Congress 2025 meeting. In her presentation and in her conversation with Modern Retina, Talcott discussed the connection between autoimmune diseases and age-related macular degeneration (AMD), emphasizing the role of inflammation in AMD development. The following conversation has been edited lightly for clarity.

5 days ago | ophthalmologytimes.com | Sydney M Crago

David Almeida, MD, PhD, MBA, a vitreoretinal surgeon and clinician scientist, presented at the Retina World Congress about OCS-01, a new dexamethasone cyclodextrin formulation for diabetic macular edema (DME). The innovative eye drop technology offers promising efficacy and safety outcomes, addressing challenges in medication delivery to the back of the eye. By allowing longer contact times and better penetration, the formulation could potentially reduce treatment burden for patients.

6 days ago | modernretina.com | Sydney M Crago

May 10, 2025Alan J. Franklin, MD, PhD, spoke with Modern Retina at Retina World Congress 2025. This meeting is taking place in Fort Lauderdale, Florida, from May 8-11, 2025. In this conversation, Franklin discussed a research study on intraoperative fluorescein angiography in surgical procedures, highlighting significant advancements in surgical visualization and patient outcomes. The following transcript has been edited lightly for clarity.

6 days ago | modernretina.com | Sydney M Crago

At the Retina World Congress 2025 in Lauderdale, Florida, Dilsher S. Dhoot, MD, from Retina Consultants of America in Santa Barbara, California shared research on the pharmaceutical candidate, OTX-TKI which is being evaluated as a potential treatment for diabetic retinopathy. The presentation focused on the HELIOS trial, which demonstrated promising results for a potential new treatment approach. The study showed that OTX-TKI was well-tolerated and safe, with no serious adverse events reported.

6 days ago | ophthalmologytimes.com | Sydney M Crago

Katherine Talcott, a retina specialist at Cole Eye Institute at the Cleveland Clinic, presented at the Retinal World Congress 2025 meeting. In her presentation and in her conversation with Ophthalmology Times, Talcott discussed the connection between autoimmune diseases and age-related macular degeneration (AMD), emphasizing the role of inflammation in AMD development. This large database study explored the link between autoimmune problems and AMD.